| Log in

Intas Pharma files DRHP with SEBI; ChrysCapital eyes 13-14x part-exit

17 June, 2013

Ahmedabad-based Intas Pharmaceuticals Ltd has filed draft red-herring prospectus (DRHP) with the market regulator for an issue which will see ChrysCapital part-exit with over 13-14 ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Intas Pharma may reconsider proposed IPO, could look at PE deal to give ChrysCap part exit

Intas Pharma may reconsider proposed IPO, could look at PE deal to give ChrysCap part exit

Lohit Jagwani 4 years ago
Intas Pharmaceuticals Ltd, which had filed its draft red-herring prospectus )...
Temasek emerges as the frontrunner to buy stake in Intas Pharma from ChrysCap

Temasek emerges as the frontrunner to buy stake in Intas Pharma from ChrysCap

Shruti Ambavat 3 years ago
Singapore’s sovereign fund Temasek Holdings has emerged as the front runner in...
Temasek buys 10.16% stake in Intas Pharma from ChrysCapital

Temasek buys 10.16% stake in Intas Pharma from ChrysCapital

Bhawna Gupta 3 years ago
Singapore’s sovereign fund Temasek has bought 10.16 per cent stake in Intas...
No Comments

Intas Pharma files DRHP with SEBI; ChrysCapital eyes 13-14x part-exit

Powered by WordPress.com VIP